Clinical Pharmacist Anticoagulant Stewardship
NCT03527615 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4000
Last updated 2018-05-17
Summary
Initiative to improve direct anticoagulant utilization involving programmatic review by clinical pharmacists in collaboration with multidisciplinary team.
Conditions
- Safety Issues
- Anticoagulant Toxicity
Interventions
- OTHER
-
Clinical Pharmacist Medication Review
Programmatic review of physician orders for direct anticoagulants by clinical pharmacists.
Sponsors & Collaborators
-
Hadassah Medical Organization
lead OTHER
Principal Investigators
-
Mordechai Muszkat, MD · Hadassah University Medical Center
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-01-01
- Primary Completion
- 2020-01-01
- Completion
- 2020-01-01
Countries
- Israel
Study Locations
More Related Trials
-
Clinical Pharmacists Role in the Management of Hypertension in Jordan
NCT01079494 ·Status: COMPLETED ·Phase: NA
-
Benefit of a Collaborative Approach to Improve the Quality of Medicines Use in Elderly Inpatients
NCT00279656 ·Status: COMPLETED ·Phase: PHASE4
-
Tailored Intervention to Improve Patient Adherence to Secondary Stroke Prevention Medication
NCT01684176 ·Status: COMPLETED ·Phase: NA
-
Enhanced Pharmacist-Managed Anticoagulation Service in a University-based Family Medicine Clinic
NCT03575936 ·Status: COMPLETED ·Phase: NA
-
:Effects of Pharmaceutical Care in Stroke Patients
NCT06129318 ·Status: COMPLETED ·Phase: NA
-
Pharmacist-led Interventions to Improve Medication Use
NCT05346770 ·Status: UNKNOWN
-
Adverse Drug Event Prevention Using Structured Pharmacist Review
NCT01467128 ·Status: COMPLETED ·Phase: PHASE4
-
The Role of Clinical Pharmacist in Monitoring Drug Therapy in the Cardiovascular and Coronary Care Units in Libya.
NCT05531552 ·Status: COMPLETED
-
Medication Safety of Elderly Patients in Hospital and Ambulatory Setting
NCT01578525 ·Status: COMPLETED ·Phase: NA
-
Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program
NCT00916214 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacist and Data Driven Quality Improvement in Primary Care
NCT03747107 ·Status: COMPLETED
-
Pharmacist-led Intervention on Hemodialysis Patients' Therapy Adherence
NCT06744738 ·Status: COMPLETED ·Phase: NA
-
A Pharmacist Implemented Pharmacogenomics Service in the Program of All-inclusive Care for the Elderly
NCT03257605 ·Status: COMPLETED
-
The Influence of Clinical Pharmacist on the Quality of Drug Prescribing and Rehabilitation Outcomes in Post-acute Hip Fractured Patients
NCT04360746 ·Status: COMPLETED ·Phase: NA
-
Cost-benefit Analysis of a Clinical Pharmacist Intervention
NCT03803033 ·Status: COMPLETED ·Phase: NA
-
Enhancing the Detection and Management of Adverse Drug Events in Nursing Homes
NCT01531088 ·Status: COMPLETED ·Phase: NA
-
Intervention to Improve Prescribing in Elderly Patients
NCT02712268 ·Status: COMPLETED ·Phase: NA
-
Systematic Follow up of Drug Treatment by Pharmacists in Secondary Prevention After Transient Ischemic Attack
NCT02089074 ·Status: COMPLETED ·Phase: NA
-
The Pharmacist in the Acute Geriatric Inpatient Treatment Team
NCT03412903 ·Status: COMPLETED
-
Pharmaceutical Care and Clinical Outcomes for the Elderly Taking Potentially Inappropriate Medication
NCT00844025 ·Status: UNKNOWN ·Phase: NA
-
The Role of a Clinical Pharmacist in the Management of Type 2 Diabetic Patients in a Primary Medical Center in Jordan
NCT06029842 ·Status: COMPLETED ·Phase: NA
-
Polymedication-Check With Insight in Patients' Medication Organisation and Comprehension of Generics
NCT03321058 ·Status: COMPLETED
-
Improving Safety After Hospitalization in Older Persons on High-Risk Medications
NCT02781662 ·Status: COMPLETED ·Phase: NA
-
Iatrogenic Drug Risk in People Over 75, With or Without Cognitive Disorders, From an Inventory of Their Family Pharmacy
NCT03686943 ·Status: WITHDRAWN
-
Impact of Mulstidisciplinary Medication Assessment Review in Surgery Departments
NCT03827031 ·Status: RECRUITING ·Phase: NA